ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      58,687.15
      1.38%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aclaris Therapeutics Inc (ACRS)

      7. Aclaris Therapeutics Inc (ACRS) News

      ACRS

      Aclaris Therapeutics (ACRS)

      Aclaris Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ACRS
      DateTimeSourceHeadlineSymbolCompany
      12/07/20176:00AMPR Newswire (US)Epidarex Capital Portfolio Company Harpoon Medical Acquired By Edwards LifesciencesNASDAQ:ACRSAclaris Therapeutics Inc
      12/01/20174:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/28/20174:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/21/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics Presents New Data at American College of Rheumatology Annual Meeting For ATI-450, a MK2 pathway Inhibito...NASDAQ:ACRSAclaris Therapeutics Inc
      11/16/20174:33PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRSAclaris Therapeutics Inc
      11/14/20174:23PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRSAclaris Therapeutics Inc
      11/09/20174:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/09/20174:05PMGlobeNewswire Inc.Aclaris Therapeutics Mourns the Passing of Board Member Richard A. BierlyNASDAQ:ACRSAclaris Therapeutics Inc
      11/07/20178:03AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRSAclaris Therapeutics Inc
      11/07/20177:32AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/07/20177:00AMGlobeNewswire Inc.Aclaris Therapeutics Reports Third Quarter 2017 Financial ResultsNASDAQ:ACRSAclaris Therapeutics Inc
      11/06/20174:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      11/03/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      11/02/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ACRSAclaris Therapeutics Inc
      10/31/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics to Announce Third Quarter 2017 Financial Results on November 7, 2017NASDAQ:ACRSAclaris Therapeutics Inc
      10/24/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces the Allowance of a U.S. Patent Application and Issuance of a Japanese Patent Covering Tofaciti...NASDAQ:ACRSAclaris Therapeutics Inc
      10/20/20175:00PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRSAclaris Therapeutics Inc
      10/10/20177:31AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ACRSAclaris Therapeutics Inc
      10/06/20177:46PMGlobeNewswire Inc.Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ACRSAclaris Therapeutics Inc
      10/04/20177:10AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRSAclaris Therapeutics Inc
      10/02/20178:00AMGlobeNewswire Inc.Best Places to Work in PA 2017NASDAQ:ACRSAclaris Therapeutics Inc
      09/20/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics to Host R&D and Investor Event on October 4, 2017 in New YorkNASDAQ:ACRSAclaris Therapeutics Inc
      09/19/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Publication of Data from Phase 2 Clinical Trial of A-101 Topical Solution for Treatment of Fac...NASDAQ:ACRSAclaris Therapeutics Inc
      09/07/20174:01PMGlobeNewswire Inc.Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ACRSAclaris Therapeutics Inc
      09/05/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics Announces Issuance of Two U.S. Patents Covering JAK Inhibitors for Treating Hair Loss DisordersNASDAQ:ACRSAclaris Therapeutics Inc
      08/24/20174:23PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ACRSAclaris Therapeutics Inc
      08/23/20175:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
      08/18/201710:16AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ACRSAclaris Therapeutics Inc
      08/17/20178:00AMGlobeNewswire Inc.Aclaris Therapeutics to Attend Upcoming Investor ConferencesNASDAQ:ACRSAclaris Therapeutics Inc
      08/16/20174:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRSAclaris Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ACRS

      Your Recent History

      BIT
      UB30FE
      UniCredit Bank
      Delayed Upgrade Clock